Clinical Trial Detail

NCT ID NCT03760666
Title A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clear Creek Bio, Inc.
Indications

acute myeloid leukemia

Therapies

Brequinar

Age Groups: adult senior

No variant requirements are available.